These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1381 related articles for article (PubMed ID: 8832943)

  • 1. Expression of autocrine motility factor receptor in cutaneous malignant melanoma.
    Nagai Y; Ishikawa O; Miyachi Y; Watanabe H
    Dermatology; 1996; 192(1):8-11. PubMed ID: 8832943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between loss of E-cadherin expression and overexpression of autocrine motility factor receptor in association with progression of human gastric cancers.
    Kawanishi K; Doki Y; Shiozaki H; Yano M; Inoue M; Fukuchi N; Utsunomiya T; Watanabe H; Monden M
    Am J Clin Pathol; 2000 Feb; 113(2):266-74. PubMed ID: 10664629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of cell motility activation factors in patients with tongue squamous cell carcinoma.
    Endo K; Shirai A; Furukawa M; Yoshizaki T
    Hum Pathol; 2006 Aug; 37(8):1111-6. PubMed ID: 16867875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of autocrine motility factor receptor correlates with overexpression of RhoC and indicates poor prognosis in hepatocellular carcinoma.
    Wang W; Yang LY; Yang ZL; Peng JX; Yang JQ
    Dig Dis Sci; 2007 Mar; 52(3):770-5. PubMed ID: 17265125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine motility factor receptor: a clinical review.
    Chiu CG; St-Pierre P; Nabi IR; Wiseman SM
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):207-17. PubMed ID: 18279062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor.
    Taniguchi K; Yonemura Y; Nojima N; Hirono Y; Fushida S; Fujimura T; Miwa K; Endo Y; Yamamoto H; Watanabe H
    Cancer; 1998 Jun; 82(11):2112-22. PubMed ID: 9610690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of autocrine motility factor receptor expression by colorectal cancer and lymph node metastases.
    Halwani Y; Kojic LD; Chan SK; Phang TP; Masoudi H; Jones SJ; Nabi IR; Wiseman SM
    Am J Surg; 2015 May; 209(5):884-9; discussion 889. PubMed ID: 25852009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine motility factor receptor as a possible urine marker for transitional cell carcinoma of the bladder.
    Korman HJ; Peabody JO; Cerny JC; Farah RN; Yao J; Raz A
    J Urol; 1996 Jan; 155(1):347-9. PubMed ID: 7490884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine motility factor receptor expression implies an unfavourable prognosis in resected stage I pulmonary adenocarcinomas.
    Kaynak K; Kara M; Oz B; Akgoz B; Sar M; Raz A
    Acta Chir Belg; 2005 Aug; 105(4):378-82. PubMed ID: 16184720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and function of the AMF receptor by human melanoma in experimental and clinical systems.
    Tímár J; Rásó E; Döme B; Ladányi A; Bánfalvi T; Gilde K; Raz A
    Clin Exp Metastasis; 2002; 19(3):225-32. PubMed ID: 12067203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple aid for objective diagnosis of malignant melanoma.
    Summers DM; Azzawi K
    Dermatol Online J; 2008 Jul; 14(7):23. PubMed ID: 18718207
    [No Abstract]   [Full Text] [Related]  

  • 12. Dysplastic nevus: Fact and fiction.
    Rosendahl CO; Grant-Kels JM; Que SK
    J Am Acad Dermatol; 2015 Sep; 73(3):507-12. PubMed ID: 26037217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine motility factor receptor expression associates with tumor progression in thymoma.
    Ohta Y; Minato H; Tanaka Y; Go T; Oda M; Watanabe Y
    Int J Oncol; 2000 Aug; 17(2):259-64. PubMed ID: 10891533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine motility factor receptor expression in patients with stage I non-small cell lung cancer.
    Kara M; Ohta Y; Tanaka Y; Oda M; Watanabe Y
    Ann Thorac Surg; 2001 Mar; 71(3):944-8. PubMed ID: 11269478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of neutral endopeptidase and motility-related protein-1 in cutaneous malignant melanoma].
    Wu Y; Zhang XB; Liu HJ; Zheng LD; Li JW; Lin Y
    Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):466-9. PubMed ID: 17845760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of autocrine motility factor (AMF) and its receptor, AMFR, in human breast cancer.
    Jiang WG; Raz A; Douglas-Jones A; Mansel RE
    J Histochem Cytochem; 2006 Feb; 54(2):231-41. PubMed ID: 16204225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review and current perspectives of cutaneous malignant melanoma.
    Evans GR; Manson PN
    J Am Coll Surg; 1994 May; 178(5):523-40. PubMed ID: 8167894
    [No Abstract]   [Full Text] [Related]  

  • 18. Overexpression of autocrine motility factor receptor (AMFR) in NIH3T3 fibroblasts induces cell transformation.
    Onishi Y; Tsukada K; Yokota J; Raz A
    Clin Exp Metastasis; 2003; 20(1):51-8. PubMed ID: 12650607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of melanoma arising within nevus spilus.
    Tavoloni Braga JC; Gomes E; Macedo MP; Pinto C; Duprat J; Begnami MD; Rezze GG
    J Am Acad Dermatol; 2014 Feb; 70(2):e31-2. PubMed ID: 24438974
    [No Abstract]   [Full Text] [Related]  

  • 20. Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors. Histologic classification and characteristics.
    Barnhill RL
    Clin Plast Surg; 2000 Jul; 27(3):331-60, viii. PubMed ID: 10941557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.